Catherine Roe,

JAD profile

Affiliation(s): 

Washington University School of Medicine

Areas of Interest: 

Alzheimer's disease, biomarkers, driving, cognitive reserve

Biography & Research: 

Catherine Roe, PhD, is Associate Professor in the Department of Neurology at Washington University School of Medicine. She obtained her doctoral degree in 1992 from Southern Illinois University, with majors in Clinical Psychology and Experimental Psychology, and spent the following decade doing clinical research using very large databases of medical and pharmacy claims at Express Scripts, Inc. Roe then began her work at Washington University in the Division of Biostatists and the Alzheimer’s Disease Research Center in 2002 and completed a postdoctoral mentored training program in Clinical Investigation at Washington University in 2010. Roe is a past winner of the National Alzheimer’s Coordinating Center Junior Investigator Award, the NIA Butler-Williams Scholars Program, the Dorismae and Harvey A. Friedman Award for Excellence in Patient-Oriented Care, Education, or Research on Aging or Aging Issues from the Harvey A. Friedman Center for Aging at Washington University, and the Mentor of the Year Award through the Institute of Clinical and Translational Sciences’ Master’s Program in Clinical Investigation at Washington University. Roe holds a patent as Co-inventor of The Assessing Demtia-8 (AD8): The Washington University Dementia Screening Test. In addition to being Associate Editor for the Journal of Alzheimer’s Disease, she is also Associate Editor for BMC Neurology’s Dementias Section; and is an ad hoc reviewer for numerous scientific journals. Roe has more published more than 85 scientific papers focusing on topics such as cognitive reserve, brain reserve, Alzheimer screening, Alzheimer disease and cancer, cerebrospinal fluid and imaging biomarkers of Alzheimer disease, preclinical Alzheimer disease, non-cognitive outcomes of Alzheimer disease, and driving performance in older adults with and without preclinical Alzheimer disease. Roe is the Principal Investigator of an R01 examining preclinical Alzheimer disease in relation to functional outcomes such as driving, as well as mood, stress, physical abilities, and sensation.